Hotline: 1800 102 2007
X
Search Business Opportunities
Jan, 10 2018

Hilleman Labs Partners With Future Vaccine Manufacturing Hub

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India Vietnam Bangladesh Uganda and China

Hilleman Laboratories to collaborate with Imperial College London, Engineering and Physical Sciences Research Council (UK) and other premier international bodies towards low-cost vaccine manufacturing.

Hilleman Laboratories, an equal joint-venture partnership between MSD and Welcome Trust, is one of the key partners of the new Future Vaccine Manufacturing Hub led by Imperial College London. The hub has been established to increase immunisation coverage across the globe and improve the response to disease outbreaks through the rapid and cost-effective deployment of vaccines. £10 million of funding has been granted by the UK Department for Health, and will be managed by the Engineering and Physical Sciences Research Council (EPSRC).

Speaking on the occasion, Dr Davinder Gill, CEO Hilleman Laboratories said, “We are honoured to collaborate with Imperial College London and EPSRC in the United Kingdom. We are gratified with this collaboration, which will help us develop our competences through international partnerships. As a partner in manufacturing research projects, we are truly hoping that the new Vaccine Manufacturing Hub will increase immunisation coverage around the globe and respond to disease outbreaks with safe and cost-effective vaccines. It will allow us to invest in innovation more effectively to explore high-quality vaccines & technologies.”

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India, Vietnam, Bangladesh, Uganda and China. Integrated approaches that will be explored by researchers at the Hub include the development of synthetic RNA vaccines which can be rapidly manufactured; the rapid production of yeast and bacterially-expressed particles that mimic components of pathogenic viruses and bacteria; and protein stabilisation to preserve vaccines at high temperatures, avoiding the need for refrigerated distribution and storage.

Comment
Related opportunities
  • Tea and Coffee Chain
    About Us: A Nibs is the centre of the Cocoa bean..
    Locations looking for expansion Rajasthan
    Establishment year 2012
    Franchising Launch Date 2012
    Investment size Rs. 10lac - 20lac
    Space required 250
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Jaipur Rajasthan
  • Ice creams & Yogurt Parlors
    About Us: Makers of Milkshakes thrives on the cravings of the..
    Locations looking for expansion Telangana
    Establishment year 2017
    Franchising Launch Date 2018
    Investment size Rs. 20lac - 30lac
    Space required 150
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Hyderabad Telangana
  • About Us: Mahindra First Choice Wheels Ltd (MFCWL) is a part..
    Locations looking for expansion Maharashtra
    Establishment year 1999
    Franchising Launch Date 2003
    Investment size Rs. 30lac - 50lac
    Space required 1000
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai City Maharashtra
  • Quick Service Restaurants
    About Us: Being dessert lovers and passionate foodies, the trio decided..
    Locations looking for expansion Maharashtra
    Establishment year 2016
    Franchising Launch Date 2018
    Investment size Rs. 10lac - 20lac
    Space required 250
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Mumbai Maharashtra
Insta-Subscribe to
The Franchising World
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities